n-methyl-3,4-methylenedioxyamphetamine has been researched along with Heart Valve Diseases in 6 studies
N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.
Heart Valve Diseases: Pathological conditions involving any of the various HEART VALVES and the associated structures (PAPILLARY MUSCLES and CHORDAE TENDINEAE).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Drugs used for the treatment of Parkinson's disease and endocrine diseases, like hyperprolactinemia, may also induce VHD." | 2.49 | Drug-induced valvular heart disease. ( Cosyns, B; Droogmans, S; Lancellotti, P; Rosenhek, R, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Tagen, M | 1 |
| Mantuani, D | 1 |
| van Heerden, L | 1 |
| Holstein, A | 1 |
| Klumpers, LE | 1 |
| Knowles, R | 1 |
| Bhattacharyya, S | 1 |
| Schapira, AH | 1 |
| Mikhailidis, DP | 1 |
| Davar, J | 1 |
| Baumann, MH | 1 |
| Rothman, RB | 2 |
| Cosyns, B | 2 |
| Droogmans, S | 2 |
| Rosenhek, R | 1 |
| Lancellotti, P | 1 |
| Setola, V | 1 |
| Hufeisen, SJ | 1 |
| Grande-Allen, KJ | 1 |
| Vesely, I | 1 |
| Glennon, RA | 1 |
| Blough, B | 1 |
| Roth, BL | 1 |
| D'haenen, H | 1 |
| Creeten, E | 1 |
| Weytjens, C | 1 |
| Franken, PR | 1 |
| Scott, B | 1 |
| Schoors, D | 1 |
| Kemdem, A | 1 |
| Close, L | 1 |
| Vandenbossche, JL | 1 |
| Bechet, S | 1 |
| Van Camp, G | 1 |
3 reviews available for n-methyl-3,4-methylenedioxyamphetamine and Heart Valve Diseases
| Article | Year |
|---|---|
The risk of chronic psychedelic and MDMA microdosing for valvular heart disease.
Topics: Hallucinogens; Heart Valve Diseases; Humans; Lysergic Acid Diethylamide; Mescaline; N-Methyl-3,4-met | 2023 |
Drug-induced fibrotic valvular heart disease.
Topics: Antiparkinson Agents; Appetite Depressants; Cabergoline; Dexfenfluramine; Dopamine Agonists; Drug Mo | 2009 |
Drug-induced valvular heart disease.
Topics: Dopamine Agonists; Ergolines; Global Health; Heart Valve Diseases; Humans; N-Methyl-3,4-methylenedio | 2013 |
3 other studies available for n-methyl-3,4-methylenedioxyamphetamine and Heart Valve Diseases
| Article | Year |
|---|---|
Neural and cardiac toxicities associated with 3,4-methylenedioxymethamphetamine (MDMA).
Topics: Animals; Brain; Heart; Heart Valve Diseases; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Neurons | 2009 |
3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Cell Division; Cells, Cultured; COS Cells; Fenfluramine; Hea | 2003 |
Possible association between 3,4-methylenedioxymethamphetamine abuse and valvular heart disease.
Topics: Adult; Dose-Response Relationship, Drug; Female; Hallucinogens; Heart Valve Diseases; Humans; Logist | 2007 |